Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 15: 2588-2600, 2004
© 2004 American Society of Nephrology
doi: 10.1097/01.ASN.0000141040.77536.AF

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fritsch, S.
Right arrow Articles by Helwig, J.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fritsch, S.
Right arrow Articles by Helwig, J.-J.

BASIC SCIENCE

Intravenous Delivery of PTH/PTHrP Type 1 Receptor cDNA to Rats Decreases Heart Rate, Blood Pressure, Renal Tone, Renin Angiotensin System, and Stress-Induced Cardiovascular Responses

Samuel Fritsch*, Veronique Lindner*,{dagger}, Sandra Welsch*, Thierry Massfelder*, Michele Grima{ddagger}, Sylvie Rothhut*, Mariette Barthelmebs* and Jean-Jacques Helwig*

*Renovascular Pharmacology and Physiology (INSERM), University Louis Pasteur School of Medicine, Strasbourg, France; {dagger}University Louis Pasteur Hospital Institute of Pathology, Strasbourg, France; and {ddagger}Institute of Pharmacology, University Louis Pasteur Medical School, Strasbourg, France

Correspondence to Dr. Jean-Jacques Helwig, Pharmacologie & Physiologie Rénovasculaires (INSERM-ULP 0015), 11 rue Humann, Bâtiment 4, 1er étage, F67085 Strasbourg Cedex, France. Phone: 333-90-24-34-54; Fax: 333-90-24-34-59; E-mail: jean-jacques.helwig{at}pharmaco-ulp.u-strasbg.fr

While parathyroid hormone type 1 receptor (PTH1R)-mediated vasodilatory, cardiac stimulatory, and renin-activating effects of exogenous PTH/PTH-related protein (PTHrP) are acknowledged, interactions of endogenous PTHrP with these systems remain unclear, mainly because the unavailability of viable PTHrP/PTH1R knockout mice. Transgenic mice overexpressing PTH1R in smooth muscle strongly have supported the PTHrP/PTH1R system as a cardiovascular system (CVS) regulator, but the consequences on renovascular (RVS) and renin-angiotensin systems (RAS) have not been explored in these studies. The aim was to develop a model in which one could study the consequences on CVS, RVS, and RAS of generalized PTH1R overexpression. Systemic PTH1R cDNA plasmid delivery was used in adult rats, a system that is amenable to studies in isolated perfused kidneys and that minimizes development-induced compensatory mechanisms. Intravenous administration of hPTH1R or green fluorescence protein–tagged hPTH1R in pcDNA3 resulted 3 wk later, in generalized expression of hPTH1R (mRNA and protein), especially in vessels, liver, heart, kidney, and central nervous system, where it is expressed physiologically. As expected, PTH1R overexpression decreased BP and renal tone. Unexpected, however, PTH1R overexpression decreased heart rate. These studies also revealed that endogenous PTHrP actually inhibits renin release and that hPTH1R overexpression tends to increase that effect. Striking, liver production and circulatory level of angiotensinogen and hence plasma renin activity were markedly reduced. Thus, abrupt PTH1R overexpression in adult rats profoundly alters the CVS, RVS, and RAS, strongly supporting the PTH/PTHrP/PTH1R system as crucial for heart and vascular tone regulation. In addition, these results revealed that PTH1R-mediated mechanisms might have protective effects against cardiovascular stress–induced responses, including stimulations in heart rate and RAS.




This article has been cited by other articles:


Home page
EndocrinologyHome page
F. Meziani, A. Tesse, S. Welsch, H. Kremer, M. Barthelmebs, R. Andriantsitohaina, F. Schneider, and A. Gairard
Expression and Biological Activity of Parathyroid Hormone-Related Peptide in Pregnant Rat Uterine Artery: Any Role for 8-Iso-Prostaglandin F2{alpha}?
Endocrinology, February 1, 2008; 149(2): 626 - 633.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
A. Halapas, P. Lembessis, I. Mourouzis, C. Pantos, D. V. Cokkinos, A. Sourla, and M. Koutsilieris
Experimental hyperthyroidism increases expression of parathyroid hormone-related peptide and type-1 parathyroid hormone receptor in rat ventricular myocardium of the Langendorff ischaemia-reperfusion model
Exp Physiol, February 1, 2008; 93(2): 237 - 246.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. A. Towler
Calciotropic Hormones and Arterial Physiology: "D"-lightful Insights
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 369 - 373.
[Full Text] [PDF]


Home page
EndocrinologyHome page
S. Welsch, E. Schordan, C. Coquard, T. Massfelder, N. Fiaschi-Taesch, J.-J. Helwig, and M. Barthelmebs
Abnormal Renovascular Parathyroid Hormone-1 Receptor in Hypertension: Primary Defect or Secondary to Angiotensin II Type 1 Receptor Activation?
Endocrinology, September 1, 2006; 147(9): 4384 - 4391.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP